FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289931310> ?p ?o ?g. }

• W4289931310 endingPage "886" @default.
• W4289931310 startingPage "877" @default.
• W4289931310 abstract "Despite advancements in the early detection of esophageal cancer, optimal radiotherapy methods for treatment of early disease have not yet been determined. Moreover, the benefit of intraluminal brachytherapy on local control or survival remains controversial. We performed a systematic review to establish the role of brachytherapy as boost therapy in stage I esophageal squamous cell carcinoma, and to evaluate associated survival outcomes.A systematic search of three bibliographic databases from January 1950 to January 2019 was conducted. All studies investigating brachytherapy for curative intent were included and palliative treatment was excluded. Primary outcomes included overall survival and disease-free survival (DFS). Secondary outcomes included loco-regional control (LRC) and toxicity grades and/or complications. Two reviewers independently abstracted data and evaluated study quality using grading of recommendations assessment, development, and evaluation, pooled results were presented through risk ratios.A total of 12 retrospective studies met inclusion criteria. The overall quality of evidence yielded a Grade 1C rating (strong recommendation, low quality evidence). Of 525 included patients, 325 patients received both external beam radiation (EBRT), and brachytherapy, 132 underwent EBRT only, and 68 received brachytherapy with and/or without chemoradiation. For patient group treated with EBRT and brachytherapy, 5-year mortality, DFS and LRC were: 43% (27-59%), 63% (49-76%) and 72% (63-80%) respectively. Rates of complications reported included 82.1% Grade 1 esophagitis for a combined external beam radiation and brachytherapy cohort, 12.3% ulcerations, and 3.3% fistulae.Brachytherapy as a combined modality is encouraging, given its relative safety and effectiveness. Further prospective analysis using higher quality evidence is warranted to evaluate oncologic outcomes and survival advantage." @default.
• W4289931310 created "2022-08-06" @default.
• W4289931310 creator A5001036125 @default.
• W4289931310 creator A5011675592 @default.
• W4289931310 creator A5018176190 @default.
• W4289931310 creator A5023078133 @default.
• W4289931310 creator A5026931551 @default.
• W4289931310 creator A5032095867 @default.
• W4289931310 creator A5039440294 @default.
• W4289931310 creator A5049866351 @default.
• W4289931310 creator A5055457781 @default.
• W4289931310 creator A5081405583 @default.
• W4289931310 creator A5087816082 @default.
• W4289931310 date "2022-11-01" @default.
• W4289931310 modified "2023-10-12" @default.
• W4289931310 title "The role of brachytherapy in treatment of stage I esophageal cancer: A systematic review" @default.
• W4289931310 cites W1499997366 @default.
• W4289931310 cites W1972722915 @default.
• W4289931310 cites W1993477338 @default.
• W4289931310 cites W2006640295 @default.
• W4289931310 cites W2024871716 @default.
• W4289931310 cites W2035993740 @default.
• W4289931310 cites W2049193446 @default.
• W4289931310 cites W2063209855 @default.
• W4289931310 cites W2065215545 @default.
• W4289931310 cites W2104409393 @default.
• W4289931310 cites W2108273820 @default.
• W4289931310 cites W2157179383 @default.
• W4289931310 cites W2161671097 @default.
• W4289931310 cites W2758114104 @default.
• W4289931310 cites W2783003100 @default.
• W4289931310 cites W2938774982 @default.
• W4289931310 cites W3128646645 @default.
• W4289931310 doi "https://doi.org/10.1016/j.brachy.2022.05.007" @default.
• W4289931310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35941072" @default.
• W4289931310 hasPublicationYear "2022" @default.
• W4289931310 type Work @default.
• W4289931310 citedByCount "0" @default.
• W4289931310 crossrefType "journal-article" @default.
• W4289931310 hasAuthorship W4289931310A5001036125 @default.
• W4289931310 hasAuthorship W4289931310A5011675592 @default.
• W4289931310 hasAuthorship W4289931310A5018176190 @default.
• W4289931310 hasAuthorship W4289931310A5023078133 @default.
• W4289931310 hasAuthorship W4289931310A5026931551 @default.
• W4289931310 hasAuthorship W4289931310A5032095867 @default.
• W4289931310 hasAuthorship W4289931310A5039440294 @default.
• W4289931310 hasAuthorship W4289931310A5049866351 @default.
• W4289931310 hasAuthorship W4289931310A5055457781 @default.
• W4289931310 hasAuthorship W4289931310A5081405583 @default.
• W4289931310 hasAuthorship W4289931310A5087816082 @default.
• W4289931310 hasConcept C121608353 @default.
• W4289931310 hasConcept C126322002 @default.
• W4289931310 hasConcept C141071460 @default.
• W4289931310 hasConcept C143998085 @default.
• W4289931310 hasConcept C146357865 @default.
• W4289931310 hasConcept C151730666 @default.
• W4289931310 hasConcept C167135981 @default.
• W4289931310 hasConcept C2775908122 @default.
• W4289931310 hasConcept C2777416452 @default.
• W4289931310 hasConcept C2779134260 @default.
• W4289931310 hasConcept C2779742542 @default.
• W4289931310 hasConcept C2779920096 @default.
• W4289931310 hasConcept C43270747 @default.
• W4289931310 hasConcept C509974204 @default.
• W4289931310 hasConcept C71924100 @default.
• W4289931310 hasConcept C86803240 @default.
• W4289931310 hasConceptScore W4289931310C121608353 @default.
• W4289931310 hasConceptScore W4289931310C126322002 @default.
• W4289931310 hasConceptScore W4289931310C141071460 @default.
• W4289931310 hasConceptScore W4289931310C143998085 @default.
• W4289931310 hasConceptScore W4289931310C146357865 @default.
• W4289931310 hasConceptScore W4289931310C151730666 @default.
• W4289931310 hasConceptScore W4289931310C167135981 @default.
• W4289931310 hasConceptScore W4289931310C2775908122 @default.
• W4289931310 hasConceptScore W4289931310C2777416452 @default.
• W4289931310 hasConceptScore W4289931310C2779134260 @default.
• W4289931310 hasConceptScore W4289931310C2779742542 @default.
• W4289931310 hasConceptScore W4289931310C2779920096 @default.
• W4289931310 hasConceptScore W4289931310C43270747 @default.
• W4289931310 hasConceptScore W4289931310C509974204 @default.
• W4289931310 hasConceptScore W4289931310C71924100 @default.
• W4289931310 hasConceptScore W4289931310C86803240 @default.
• W4289931310 hasIssue "6" @default.
• W4289931310 hasLocation W42899313101 @default.
• W4289931310 hasLocation W42899313102 @default.
• W4289931310 hasOpenAccess W4289931310 @default.
• W4289931310 hasPrimaryLocation W42899313101 @default.
• W4289931310 hasRelatedWork W2043597413 @default.
• W4289931310 hasRelatedWork W2055348823 @default.
• W4289931310 hasRelatedWork W2061330376 @default.
• W4289931310 hasRelatedWork W2122571195 @default.
• W4289931310 hasRelatedWork W2788839829 @default.
• W4289931310 hasRelatedWork W2966036943 @default.
• W4289931310 hasRelatedWork W3029213237 @default.
• W4289931310 hasRelatedWork W3107045007 @default.
• W4289931310 hasRelatedWork W3132851114 @default.
• W4289931310 hasRelatedWork W4206581437 @default.
• W4289931310 hasVolume "21" @default.

• next